Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-29 @ 2:12 AM
Study NCT ID:
NCT03680560
Status:
TERMINATED
Last Update Posted:
2020-03-31
First Post:
2018-09-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
Sponsor:
Cogent Biosciences, Inc.
Organization: